US FDA approves landmark pancreatic cancer drug Rasonque: Here's how much will it cost you
Mint
—
The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, Rasonque (daraxonrasib).
Here's all you need to know about it.